Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : BJCT-BIOJECT-needle less injection product -- Ignore unavailable to you. Want to Upgrade?

To: Marc Kahn who wrote (88)	11/26/1997 3:44:00 PM
From: Rsg	Respond to of 534

Marc & All, Finished reading all 88 posts. Informative, and, the fact that some of you would get a shot in the name of dd, very impressive. Been following BJCT for a couple of months. Was skeptical about the product, too many friends having felt too much "sensation" from the needleless vaccine (one friend compared it to a staple gun), but I like the agreement with ELAN. Bought in last week at $1 3/8. Sort of high, but I figured that since it was the same price as the insider who bought 40K of shares on 10/6-7 paid, I couldn't be too off target. Rick G

To: Marc Kahn who wrote (88)	11/28/1997 3:24:00 PM
From: Michael C. Woodward	Respond to of 534

Stock finally moved up to 1 17/32 thus far today on 235,000 shares transacted. I hope it keeps moving up. I recently put my very conservative 80 year old mother in it. I'm still anticipating good gains in 1st qtr 1998.